From the, School of Cancer & Pharmaceutical Sciences, King's College London, London, UK.
Department of Medicine Solna, Division of Clinical Epidemiology, Karolinska Institutet and Karolinska University Hospital, Stockholm, Sweden.
J Intern Med. 2020 Jun;287(6):723-733. doi: 10.1111/joim.13036. Epub 2020 Mar 3.
A family history of colorectal cancer (CRC) is an established risk factor for developing CRC, whilst the impact of family history on prognosis is unclear. The present study assessed the association between family history and prognosis and, based on current evidence, explored whether this association was modified by age at diagnosis.
Using data from the Swedish Colorectal Cancer Registry (SCRCR) linked with the Multigeneration Register and the National Cancer Register, we identified 31 801 patients with a CRC diagnosed between 2007 and 2016. The SCRCR is a clinically rich database which includes information on the cancer stage, grade, location, treatment, complications and postoperative follow-up.
We estimated excess mortality rate ratios (EMRR) for relative survival and hazard ratios (HR) for disease-free survival with 95% confidence intervals (CIs) using flexible parametric models. We found no association between family history and relative survival (EMRR = 0.96, 95% CIs: 0.89-1.03, P = 0.21) or disease-free survival (HR = 0.98, 95% CIs: 0.91-1.06, P = 0.64). However, age was found to modify the impact of family history on prognosis. Young patients (<50 at diagnosis) with a positive family history had less advanced (i.e. stages I and II) cancers than those with no family history (OR = 0.71, 95% CI: 0.56-0.89, P = 0.004) and lower excess mortality even after adjusting for cancer stage (EMMR = 0.63, 95% CIs: 0.47-0.84, P = 0.002).
Our results suggest that young individuals with a family history of CRC may have greater health awareness, attend opportunistic screening and adopt lifestyle changes, leading to earlier diagnosis and better prognosis.
结直肠癌(CRC)家族史是发生 CRC 的既定危险因素,而家族史对预后的影响尚不清楚。本研究评估了家族史与预后之间的关联,并根据现有证据探讨了这种关联是否受诊断时年龄的影响。
使用来自瑞典结直肠癌登记处(SCRCR)的数据,该数据与多代登记处和国家癌症登记处相关联,我们确定了 31801 例 2007 年至 2016 年间诊断为 CRC 的患者。SCRCR 是一个临床资料丰富的数据库,其中包括癌症分期、分级、位置、治疗、并发症和术后随访等信息。
我们使用灵活的参数模型估计了相对生存率的超额死亡率比(EMRR)和无病生存率的风险比(HR)及其 95%置信区间(CI)。我们发现家族史与相对生存率(EMRR=0.96,95%CI:0.89-1.03,P=0.21)或无病生存率(HR=0.98,95%CI:0.91-1.06,P=0.64)之间没有关联。然而,年龄被发现会影响家族史对预后的影响。有阳性家族史的年轻患者(诊断时<50 岁)的癌症分期比没有家族史的患者更不严重(即 I 期和 II 期)(OR=0.71,95%CI:0.56-0.89,P=0.004),即使在调整癌症分期后,超额死亡率也更低(EMMR=0.63,95%CI:0.47-0.84,P=0.002)。
我们的研究结果表明,有 CRC 家族史的年轻个体可能具有更强的健康意识,会参加机会性筛查并采取生活方式的改变,从而导致更早的诊断和更好的预后。